Repligen | RGEN - Ebitda





Ebitda Veränderung Datum
Agilent USD 577M 77M 2026-06
Align Technology USD 229.14M 31.74M 2026-03
Bio Techne USD 115.94M 763K 2026-06
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Bruker USD 143.2M 33.2M 2026-06
Charles River Laboratories USD 272.95M 43.14M 2026-06
Danaher USD 1.84B 81M 2026-06
Dentsply International USD 190M 61M 2026-06
General Electric Aerospace USD 3.06B 219M 2026-06
Henry Schein USD 288M 1000K 2026-06
Illumina USD 330M 80M 2026-06
IQVIA Holdings USD 994M 62M 2026-06
Mettler Toledo International USD 322.64M 43.66M 2026-06
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Pfizer USD 6.01B 18M 2026-06
Repligen USD 43.77M 3.76M 2026-06
Revvity USD 228.18M 44.73M 2026-06
Standard Biotools USD -8.01M 7.8M 2026-03
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Waters USD 712M 545M 2026-06
West Pharmaceutical Services USD 243.6M 17.4M 2026-06